Ilan Ganot - 03 Jan 2024 Form 4 Insider Report for Solid Biosciences Inc. (SLDB)

Role
Director
Signature
/s/ by David Tyrone Howton as attorney-in-fact for Ilan Ganot
Issuer symbol
SLDB
Transactions as of
03 Jan 2024
Net transactions value
-$6,052
Form type
4
Filing time
05 Jan 2024, 19:04:56 UTC
Previous filing
05 Dec 2023
Next filing
30 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLDB Common Stock Options Exercise +2,993 +47% 9,309 03 Jan 2024 Wife F1
transaction SLDB Common Stock Sale $6,052 -1,142 -12% $5.30 8,167 03 Jan 2024 Wife F2
holding SLDB Common Stock 90,924 03 Jan 2024 Direct F3
holding SLDB Common Stock 19,394 03 Jan 2024 See Footnote F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLDB Restricted Stock Units Options Exercise $0 -2,993 -25% $0.000000 8,982 03 Jan 2024 Common Stock 2,993 Wife F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert to common stock on a one-for-one basis.
F2 This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The sales do not represent a discretionary trade by Ms. Ganot.
F3 Represents 86,882 shares held by Mr. Ganot as an individual, and 4,042 shares held by Mr. Ganot and Annie Ganot as joint tenants with right of survivorship.
F4 Represents 19,394 shares held by Adam Ganot and Annie Ganot, and their successors, as the trustees for the Ilan Ganot 2017 Irrevocable Trust dated March 3, 2017.
F5 On January 3, 2023 (the "Grant Date"), Ms. Ganot was granted 11,975 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date.